Form D · Biotechnology

Biomatrica, Inc.

San Diego, CA · CIK 0001378066

Offering snapshot reported Dec 22, 2017 · SEC filing

Reported sold
$18.1M
Offering amount: $21.1M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 1, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 22, 2017Initial$18,145,597No comparison18SEC filing
Sep 1, 2011Initial$3,024,071No comparison2SEC filing
Feb 15, 2011Amendment$1,192,160No comparison19SEC filing
Feb 15, 2011InitialYet to sellNo comparison0SEC filing
Dec 23, 2010InitialYet to sellNo comparison0SEC filing
Feb 12, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Oct 4, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-301575

Source: Form D, filed Dec 22, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tony Broad Executive
Nick Ecos Director, Executive
Francois Ferre Director
Joe Markee Director
Joseph Markee Director, Executive
Rolf Muller Director, Executive
Tolf Muller Director, Executive
Judy Muller Cohn Director, Executive
John Thompson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5627 Oberlin Dr., Suite 120
San Diego, CA, 92121